SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 246.06 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 8.83 |
| Book Value / Share | 0.10 |
| Price / Book | n/a |
| NCAV ($M) | -16.48 |
| NCAV / Share | -0.18 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.24 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -1.72 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.60 |
| Current Ratio | 2.60 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 85.74 |
| Assets | 111.06 |
| Liabilities | 102.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 20.12 |
| Operating Income | -51.58 |
| Net Income | -49.47 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.90 |
| Cash from Investing | 9.20 |
| Cash from Financing | -6.01 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| INRLF – Valneva SE | INTI – Inhibitor Therapeutics, Inc. |
| IOFNF – Iofina plc | IPIX – Innovation Pharmaceuticals Inc. |
| IPSEF – Ipsen S.A. |
Financial data and stock pages provided by
Fintel.io